SEC Comment Letter 0000000000-23-012494 to Verastem, Inc. (VSTM)
Verastem, Inc.
Date: Nov. 14, 2023 · CIK: 0001526119 · Accession: 0000000000-23-012494
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275408
Letter
United States securities and exchange commission logo November 14, 2023 Daniel Paterson Chief Executive Officer Verastem, Inc. 117 Kendrick Street, Suite 500 Needham, MA 02494 Re:Verastem, Inc. Registration Statement on Form S-3 Filed November 8, 2023 File No. 333-275408 Dear Daniel Paterson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dillon Hagius at 202-551-7967 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Marko S. Zatylny
Show Raw Text
United States securities and exchange commission logo
November 14, 2023
Daniel Paterson
Chief Executive Officer
Verastem, Inc.
117 Kendrick Street, Suite 500
Needham, MA 02494
Re:Verastem, Inc.
Registration Statement on Form S-3
Filed November 8, 2023
File No. 333-275408
Dear Daniel Paterson:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dillon Hagius at 202-551-7967 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Marko S. Zatylny